Year |
Citation |
Score |
2020 |
Schardien KA, Soto MS, Inbody L, Berchiche Y, Kehrl JH, Bradfield C, Free RB, Sibley DR. Investigation of G protein‐coupled receptor kinase 2 (GRK2) regulation of D
2
dopamine receptor signaling: effects of GRK2 functional domains and pharmacologic and genetic inhibition of GRK2 activity The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05825 |
0.429 |
|
2019 |
Rico CA, Berchiche YA, Horioka M, Peeler JC, Lorenzen E, Tian H, Kazmi MA, Fürstenberg A, Gaertner H, Hartley O, Sakmar TP, Huber T. High-Affinity Binding of Chemokine Analogs that Display Ligand Bias at the HIV-1 Coreceptor CCR5. Biophysical Journal. PMID 31421836 DOI: 10.1016/J.Bpj.2019.07.043 |
0.399 |
|
2018 |
Lorenzen E, Ceraudo E, Berchiche YA, Rico CA, Fürstenberg A, Sakmar TP, Huber T. G protein subtype-specific signaling bias in a series of CCR5 chemokine analogs. Science Signaling. 11. PMID 30327411 DOI: 10.1126/Scisignal.Aao6152 |
0.406 |
|
2016 |
Berchiche YA, Sakmar TP. CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways. Molecular Pharmacology. PMID 27512119 DOI: 10.1124/Mol.116.105502 |
0.548 |
|
2011 |
Berchiche YA, Gravel S, Pelletier ME, St-Onge G, Heveker N. Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization. Molecular Pharmacology. 79: 488-98. PMID 21088225 DOI: 10.1124/Mol.110.068486 |
0.702 |
|
2011 |
Berchiche YA, Chow KY, Lagane B, Leduc M, Percherancier Y, Fujii N, Tamamura H, Bachelerie F, Heveker N. Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and Gα i activation (THe Journal of Biological Chemistry (2007) 282, (5111-5115)) Journal of Biological Chemistry. 286: 29440. DOI: 10.1074/Jbc.A111.600270 |
0.708 |
|
2010 |
Gravel S, Malouf C, Boulais PE, Berchiche YA, Oishi S, Fujii N, Leduc R, Sinnett D, Heveker N. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains. The Journal of Biological Chemistry. 285: 37939-43. PMID 20956518 DOI: 10.1074/Jbc.C110.147470 |
0.718 |
|
2009 |
Rafei M, Berchiche YA, Birman E, Boivin MN, Young YK, Wu JH, Heveker N, Galipeau J. An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis. Journal of Immunology (Baltimore, Md. : 1950). 183: 1759-66. PMID 19592643 DOI: 10.4049/Jimmunol.0900523 |
0.642 |
|
2009 |
Kalatskaya I, Berchiche YA, Gravel S, Limberg BJ, Rosenbaum JS, Heveker N. AMD3100 is a CXCR7 ligand with allosteric agonist properties. Molecular Pharmacology. 75: 1240-7. PMID 19255243 DOI: 10.1124/Mol.108.053389 |
0.709 |
|
2008 |
Rafei M, Berchiche Y, Wu JH, Birman E, Heveker N, Galipeau J. 146 A GMCSF and CCL2 fusion chimera induces apoptosis in CCR2 expressing lymphomyeloid cells and promotes xenotolerance Cytokine. 43: 270. DOI: 10.1016/J.Cyto.2008.07.188 |
0.582 |
|
2007 |
Desjardins SF, Berchiche YA, Haddad E, Heveker N. [Multiple talents of the chemokine receptor-CXCR4]. MéDecine Sciences : M/S. 23: 980-4. PMID 18021711 DOI: 10.1051/Medsci/20072311980 |
0.686 |
|
2007 |
Berchiche YA, Chow KY, Lagane B, Leduc M, Percherancier Y, Fujii N, Tamamura H, Bachelerie F, Heveker N. Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G(alpha)(i) activation. The Journal of Biological Chemistry. 282: 5111-5. PMID 17197449 DOI: 10.1074/jbc.C600270200 |
0.694 |
|
2006 |
Dulude D, Berchiche YA, Gendron K, Brakier-Gingras L, Heveker N. Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1. Virology. 345: 127-36. PMID 16256163 DOI: 10.1016/J.Virol.2005.08.048 |
0.628 |
|
2005 |
Percherancier Y, Berchiche YA, Slight I, Volkmer-Engert R, Tamamura H, Fujii N, Bouvier M, Heveker N. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. The Journal of Biological Chemistry. 280: 9895-903. PMID 15632118 DOI: 10.1074/Jbc.M411151200 |
0.712 |
|
Show low-probability matches. |